I’rom Group 2372.T JPX closed JPY 2790.00 on 06 Feb 2026: Oversold bounce insight

2372.T stock closed at JPY 2790.00 on 06 Feb 2026, presenting a near-term oversold bounce setup after recent choppy trading. The price sits slightly above the 50-day average of JPY 2789.08 and above the 200-day average of JPY 2752.09, which supports a tactical mean-reversion view for short-term traders. Volume was 22,800.00 shares versus an average of 42,368.00, keeping moves muted but orderly. We assess risk-reward using valuation, liquidity and sector context for I’rom Group Co., Ltd. (2372.T) on the JPX market in Japan.

Quick price and volume snapshot for 2372.T stock

I’rom Group (2372.T) closed at JPY 2790.00 with a day range of JPY 2790.00–2793.00 and a year range of JPY 1750.00–2797.00. Market capitalization stood at JPY 33773787000.00 and traded volume was 22,800.00, below the 50-day average volume of 42,368.00, indicating limited immediate conviction from large flows. This price location near the recent high compresses downside in the very short term and supports an oversold bounce trade idea.

Fundamentals and valuation metrics for I’rom Group (2372.T stock)

Earnings per share are JPY 21.20 with a reported PE of 131.60, and a price-to-book ratio of 2.58, showing the stock trades at a premium to book but with modest reported profitability. Key ratios include debt-to-equity 1.38, return on equity 0.58%, and current ratio 1.20, which point to a capital structure with leverage and thin near-term returns. These metrics make 2372.T stock more suited to selective, event-driven trades than broad-value allocations.

Technical setup: oversold bounce case for 2372.T stock

Price sitting near the 50-day average supports a short-term bounce trade after earlier weakness, especially given the low on-day volatility (ATR 1.50). Relative momentum indicators are limited by data but the close-to-average price suggests a mean-reversion opportunity rather than a breakout. Traders should watch a failed follow-through as a sign to exit quickly and use tight risk controls when trading this oversold bounce idea.

Meyka AI grade and model outlook for 2372.T stock

Meyka AI rates 2372.T with a score out of 100: the model gives 65.62/100 (Grade B, HOLD). This grade factors in S&P 500 comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a 1-year value of JPY 2671.01 and a 3-year value of JPY 2951.00, which implies a near-term downside of -4.28% and a three-year upside of +5.79% versus the current JPY 2790.00. Forecasts are model-based projections and not guarantees.

Catalysts, risks and sector context for 2372.T stock

Catalysts include clinical-trial progress, new contract research wins and improved operating margins in the Healthcare sector. I’rom Group operates in Medical – Care Facilities and benefits from defensive demand trends in Japan but still faces execution risk tied to R&D results and receivables (days sales outstanding 156.32). Sector peers show average P/E around 24.14, so 2372.T stock’s pricing at a high PE reflects growth expectations that must be met by earnings progress.

Trade tactics and position sizing for an oversold bounce strategy

For traders targeting the oversold bounce in 2372.T stock, use a staggered entry: scale in at JPY 2785.00–2795.00 with a tight stop below JPY 2750.00 and a first profit target near JPY 2950.00 based on the 3-year model pivot. Keep position size small relative to portfolio volatility and monitor daily volume above 42,368.00 to validate continuation. Use event risk controls around clinical updates and earnings windows.

Final Thoughts

Key takeaways: 2372.T stock closed at JPY 2790.00 on 06 Feb 2026 and offers a defined oversold bounce opportunity with limited near-term downside while longer-term returns depend on clinical and operational execution. Valuation is rich on a PE of 131.60 and leverage is notable with debt-to-equity 1.38, so we frame this as a tactical trade rather than a buy-and-hold idea. Meyka AI’s forecast model projects JPY 2671.01 at one year (implied -4.28%) and JPY 2951.00 at three years (implied +5.79%) versus the current JPY 2790.00, highlighting mixed near-term and mid-term prospects. Traders should size positions conservatively, use tight stops, and watch liquidity and clinical milestones. This analysis is delivered by Meyka AI, an AI-powered market analysis platform; forecasts are model-based projections and not guarantees.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.